Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: A multi-centred, placebo-controlled preliminary clinical trial
- 31 October 2011
- journal article
- research article
- Published by Elsevier BV in Sleep Medicine
- Vol. 12 (9), 906-913
- https://doi.org/10.1016/j.sleep.2011.06.009
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A randomized, double‐blind, placebo controlled, multi‐center study of intravenous iron sucrose and placebo in the treatment of restless legs syndromeMovement Disorders, 2009
- A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndromeSleep Medicine, 2009
- Ferric CarboxymaltoseDrugs, 2009
- Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trialThe Lancet Neurology, 2008
- Clinical update: intravenous iron for anaemiaThe Lancet, 2007
- Efficacy and safety of pramipexole in restless legs syndromeNeurology, 2006
- Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study—The PRELUDE studySleep Medicine, 2006
- On the relative safety of parenteral iron formulationsNephrology Dialysis Transplantation, 2004
- The treatment of restless legs syndrome with intravenous iron dextranSleep Medicine, 2004
- Restless Legs SyndromeJournal of Clinical Neurophysiology, 2001